---
figid: PMC10920452__11912_2024_1506_Fig2_HTML
figtitle: Glycogen synthase kinase-3B (GSK-3B) diminishes Beta-Catenin levels, a key
  player in the Wnt signaling pathway, by phosphorylating Serine/Threonine (Ser/Thr)
  sites at its N-terminal end
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10920452
filename: 11912_2024_1506_Fig2_HTML.jpg
figlink: /pmc/articles/PMC10920452/figure/F2
number: F2
caption: Glycogen synthase kinase-3β (GSK-3β) diminishes β-Catenin levels, a key player
  in the Wnt signaling pathway, by phosphorylating Serine/Threonine (Ser/Thr) sites
  at its N-terminal end. This leads to ubiquitination and subsequent breakdown by
  proteasomes. In sinonsal glomangiopericytoma (SGP), mutations in the CTNNB1 gene,
  which alter one of the vital Ser/Thr sites in the β-catenin’s GSK-3β region, lead
  to the stabilization of β-catenin. This, in turn, activates the β-catenin/T-cell
  factor/lymphoid enhancer factor (TCF/LEF) target genes. LRP, lipoprotein receptor-related
  proteins; CK1α, casein kinase 1α; APC, adenomatous polyposis coli (Figure created
  using BioRender, Toronto, ON, Canada)
papertitle: Integrated Molecular and Histological Insights for Targeted Therapies
  in Mesenchymal Sinonasal Tract Tumors
reftext: Cosima C. Hoch, et al. Curr Oncol Rep. 2024 Feb 20;26(3).
year: '2024'
doi: 10.1007/s11912-024-01506-9
journal_title: Current Oncology Reports
journal_nlm_ta: Curr Oncol Rep
publisher_name: Springer US
keywords: Mesenchymal sinonasal tract tumors | Sinonasal tract angiofibroma | Sinonasal
  glomangiopericytoma | Biphenotypic sinonasal sarcoma | Skull base chordoma | Targeted
  therapy
automl_pathway: 0.9442319
figid_alias: PMC10920452__F2
figtype: Figure
redirect_from: /figures/PMC10920452__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10920452__11912_2024_1506_Fig2_HTML.html
  '@type': Dataset
  description: Glycogen synthase kinase-3β (GSK-3β) diminishes β-Catenin levels, a
    key player in the Wnt signaling pathway, by phosphorylating Serine/Threonine (Ser/Thr)
    sites at its N-terminal end. This leads to ubiquitination and subsequent breakdown
    by proteasomes. In sinonsal glomangiopericytoma (SGP), mutations in the CTNNB1
    gene, which alter one of the vital Ser/Thr sites in the β-catenin’s GSK-3β region,
    lead to the stabilization of β-catenin. This, in turn, activates the β-catenin/T-cell
    factor/lymphoid enhancer factor (TCF/LEF) target genes. LRP, lipoprotein receptor-related
    proteins; CK1α, casein kinase 1α; APC, adenomatous polyposis coli (Figure created
    using BioRender, Toronto, ON, Canada)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - SH3TC2
  - CSNK1A1
  - CTNNB1
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - HNF4A
---
